+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Impetigo Treatment Market 2019-2023 - Product Image

Global Impetigo Treatment Market 2019-2023

  • ID: 4718437
  • Report
  • November 2018
  • Region: Global
  • 104 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Cutanea Life Sciences
  • GlaxoSmithKline
  • LEO Pharma
  • MORE
About this market

The evolving resistance of microorganisms is likely to push growth in the market. There has been evolving resistance owing to the frequent usage of oral antibiotics. Hence manufacturers are developing more effective antibiotics to treat skin infections.

The analysts have predicted that the impetigo treatment market will register a CAGR of about 7% by 2023.

Market Overview

Low cost of treatment

Impetigo is a common, highly contagious bacterial skin infection. However, the infection can be treated easily without spending much.

Side effects of drugs

Impetigo is a bacterial infection of the skin which is treated with topical antibiotics or oral drugs. However, few side effects of these drugs may pose a challenge to the market.

For the detailed list of factors that will drive and challenge the growth of the impetigo treatment market during the 2019-2023, view the full report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Cutanea Life Sciences and GlaxoSmithKline, the competitive environment is quite intense. Factors such as the low cost of treatment and the low cost of treatment, will provide considerable growth opportunities to impetigo treatment manufactures. Cutanea Life Sciences, GlaxoSmithKline, LEO Pharma, and Medimetriks Pharmaceuticals are some of the major companies covered in this report.

With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the markets competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cutanea Life Sciences
  • GlaxoSmithKline
  • LEO Pharma
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: PIPELINE ANALYSIS
  • Pipeline analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Topical - Market size and forecast 2018-2023
  • Oral - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: SEGMENTATION BY DRUG CLASS

PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Market trends
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Cutanea Life Sciences
  • GlaxoSmithKline
  • LEO Pharma
  • Medimetriks Pharmaceuticals
PART 16: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global dermatological drugs market
Exhibit 02: Segments of global dermatological drugs market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Topical - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Topical - Year-over-year growth 2019-2023 (%)
Exhibit 21: Oral - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Oral - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 29: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Vendor landscape
Exhibit 37: Landscape disruption
Exhibit 38: Vendors covered
Exhibit 39: Vendor classification
Exhibit 40: Market positioning of vendors
Exhibit 41: Cutanea Life Sciences - Vendor overview
Exhibit 42: Cutanea Life Sciences - Organizational developments
Exhibit 43: Cutanea Life Sciences - Key offerings
Exhibit 44: GlaxoSmithKline - Vendor overview
Exhibit 45: GlaxoSmithKline - Business segments
Exhibit 46: GlaxoSmithKline - Organizational developments
Exhibit 47: GlaxoSmithKline - Geographic focus
Exhibit 48: GlaxoSmithKline - Segment focus
Exhibit 49: GlaxoSmithKline - Key offerings
Exhibit 50: LEO Pharma - Vendor overview
Exhibit 51: LEO Pharma - Organizational developments
Exhibit 52: LEO Pharma - Geographic focus
Exhibit 53: LEO Pharma - Key offerings
Exhibit 54: Medimetriks Pharmaceuticals - Vendor overview
Exhibit 55: Medimetriks Pharmaceuticals - Organizational developments
Exhibit 56: Medimetriks Pharmaceuticals - Key offerings
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Cutanea Life Sciences
  • GlaxoSmithKline
  • LEO Pharma
  • MORE
Global Impetigo Treatment Market 2019-2023

The author of the report recognizes the following companies as the key players in the global impetigo treatment market: Cutanea Life Sciences, GlaxoSmithKline, LEO Pharma, and Medimetriks Pharmaceuticals.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the evolving resistance of microorganisms.”

According to the report, one of the major drivers for this market is the low cost of treatment.

Further, the report states that one of the major factors hindering the growth of this market is the side effects of drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Cutanea Life Sciences
  • GlaxoSmithKline
  • LEO Pharma
  • Medimetriks Pharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll